Marianne Kjalke's research works | Novo Nordisk, Copenhagen and other places
Mim8 clinical development program: an overview of the FRONTIER studies
Study Set to Assess Mim8 Therapy in People With Hemophilia A
A multiple ascending dose study of Mim8 in patients with severe haemophilia A with or without factor VIII inhibitors
A factor VIIIa–mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice - ScienceDirect
Novo Nordisk outlines strategy for revamped rare diseases unit | BioWorld
ISTH 2022 – Novo moves forward with its Hemlibra rival | Evaluate
Novo makes a rare disease push | Evaluate
Mette Loftager's research works | Novo Nordisk, Copenhagen and other places
Summer 2022 haemophilia trial update - European Pharmaceutical Review
%20for%20Hemophilia.png?md=1 "NNC0365-3769 (Mim8) for Hemophilia Clinical Trial 2023 | Power")
NNC0365-3769 (Mim8) for Hemophilia Clinical Trial 2023 | Power
Bertrand Delsuc on Twitter: "Novo Nordisk R&D milestones Q3'20 $NOVO-B semaglutide ph3 initiating next year in NASH $GMAB mim8 ph1/2 in Hemophilia A readout next year https://t.co/wdlY21E8SB" / Twitter
Novo Nordisk's Concizumab Could Be First In New Class For Hemophilia :: Scrip
A factor VIIIa–mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice - ScienceDirect
Mim8 data sees potential as once monthly treatment for haemophilia A - European Pharmaceutical Manufacturer
Mim8 - a Next-Generation FVIII Mimetic Bi-Specific Antibody - Potently Restores the Hemostatic Capacity in Hemophilia a Settings in Vitro and In Vivo - ScienceDirect
Summer 2022 haemophilia trial update - European Pharmaceutical Review
A Novel FVIIIa-Mimetic Bispecific Antibody, Mim8, Enhances FIXa Proteolytic Activity While Allowing for Efficient, Lipid-Dependent Assembly with FX - ISTH Congress Abstracts
A novel next‐generation FVIIIa mimetic, Mim8, has a favorable safety profile and displays potent pharmacodynamic effects: Results from safety studies in cynomolgus monkeys - Lauritzen - 2022 - Journal of Thrombosis and
